---
title: "Coya Therapeutics amends filing to name Mark Pavao to audit committee"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295278164.md"
description: "Coya Therapeutics filed an amended Form 8-K to update board committee assignments. Mark H. Pavao was appointed to the Audit Committee on August 6, 2026, effective immediately. The committee now includes Dov Goldstein as chair, along with Ann Lee, Dieter Weinand, and Mark H. Pavao."
datetime: "2026-08-07T21:03:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295278164.md)
  - [en](https://longbridge.com/en/news/295278164.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295278164.md)
generator: "portal-rs"
---

# Coya Therapeutics amends filing to name Mark Pavao to audit committee

-   Coya Therapeutics filed an amended Form 8-K to update board committee assignments disclosed in its March 29, 2026 report. \* Mark H. Pavao was appointed to the board’s Audit Committee on Aug. 6, 2026, effective immediately. \* The Audit Committee now includes Dov Goldstein as chair, Ann Lee, Dieter Weinand, Mark H. Pavao. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-340449), on August 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [COYA.US](https://longbridge.com/en/quote/COYA.US.md)

## Related News & Research

- [Coya Therapeutics posts September 2026 investor presentation on neurodegeneration pipeline](https://longbridge.com/en/news/297669200.md)
- [COYA: Treg-based combination therapies show promise in ALS and FTD, with key data expected in 2027](https://longbridge.com/en/news/297671410.md)
- [Abeona Therapeutics director Mark Alvino disposes of 15,000 common shares worth $87,966](https://longbridge.com/en/news/297702333.md)
- [Alamar Biosciences appoints Robert Ragusa to board](https://longbridge.com/en/news/297691608.md)
- [Callan JMB director Mark Meller resigns, exits audit chair role](https://longbridge.com/en/news/297693809.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**